Lungs News and Research

RSS

COVID-19 survivors under 40 more likely to recover from smell and taste loss, study finds

Sense of smell or taste returns within six months for 4 out of every 5 COVID-19 survivors who have lost these senses, and those under 40 are more likely to recover these senses than older adults, an ongoing Virginia Commonwealth University study found.

5 Oct 2021

A possible protective genetic polymorphism in COVID-19

A new study discusses the role of a mucin gene enhancer on the clinical phenotype of the COVID-19.

5 Oct 2021

UD chemical engineer aims to improve the delivery of therapeutic medicines to the body

The human body has built-in protections to keep pathogens out. That sneezing fit or stuffy nose when you have a cold? That's your body leveraging mucosal linings in your respiratory system to expel the offending virus.

5 Oct 2021

Novel mouse model uncovers resistance mechanism in human breast cancers

Scientists at the Medical College of Wisconsin Cancer Center and an international team of collaborators have generated mice with an improved hormone profile that supports growth and metastatic spread of implanted human breast tumors.

5 Oct 2021

J&J vaccine prevents SARS-CoV-2-induced thrombosis and inflammation in hamsters

In a recent study, researchers performed bulk RNA-Seq transcriptomic profiling of lungs from vaccinated and unvaccinated hamsters with the Janssen vaccine.

4 Oct 2021

New AI algorithm may quickly, effectively diagnose deep vein thrombosis

A team of researchers are developing the use of an artificial intelligence (AI) algorithm with the aim of diagnosing deep vein thrombosis (DVT) more quickly and as effectively as traditional radiologist-interpreted diagnostic scans, potentially cutting down long patient waiting lists and avoiding patients unnecessarily receiving drugs to treat DVT when they don't have it.

4 Oct 2021

CHLA investigators receive NIH funding to lead study on healthy brain development

When children are sick, clinicians can consult a known standard for how their heart, lungs and kidneys should be growing and working.

4 Oct 2021

Persistent leukocyte changes three months after mild SARS-CoV-2 infection

A recent study discusses the rate of changes in peripheral blood white cells in individuals who have recovered from SARS-CoV-2 infection.

3 Oct 2021

Hospitalizations related to COVID-19 can be reduced by using prescribed blood thinners

The NIH has reported that many individuals with COVID-19 develop abnormal blood clots from high inflammation, which can lead to serious health complications and mortality.

3 Oct 2021

Two-mAb cocktail prevents SARS-CoV-2 infection, study suggests

A promising study shows that a combination of two monoclonal antibodies effectively neutralized SARS-CoV-2 in monkeys and proved efficacious against newer variants of concern in vitro.

1 Oct 2021

Dual therapy improves cardiac outcomes in pediatric patients suffering from MIS-C

A recent study by a multidisciplinary team of cardiologists and infectious disease specialists at Children's Hospital Colorado (Children's Colorado) found that pediatric patients suffering from Multisystem Inflammatory Syndrome (MIS-C) who received initial, intensified therapy consisting of intravenous immunoglobulin (IVIG) plus Infliximab had improved cardiac outcomes versus those who received IVIG alone.

30 Sep 2021

Pediatric transplant recipients mount a more robust immune response after two COVID-19 vaccine doses

In a study published today in the American Journal of Transplantation, Johns Hopkins Medicine researchers say that children between the ages of 12 and 18 who have received solid organ transplants appear to mount a more robust immune response than their adult counterparts after a standard two-dose vaccination regimen against SARS-CoV-2, the virus that causes COVID-19.

30 Sep 2021

Scientists describe SARS-CoV-2 uptake in tissue-resident human macrophages enhanced by virus-specific antibodies

Now, in a new news study posted to the bioRxiv* preprint server, researchers have successfully induced similar chronicity associated with SARS-CoV-2 infection in MISTRG6-hACE2 humanized mice.

29 Sep 2021

4DMedical’s unique XV Technology reveals long-term effects of COVID-19

The world’s first four-dimensional visual insight into the residual effects of COVID-19 or ‘long COVID’ providing an unprecedented ability for patients, clinicians and researchers to understand the ongoing impact of this disease has been obtained using 4DMedical’s unique XV Technology.

29 Sep 2021

Study reports on ex vivo drug delivery system for delivering MSCs to kidney disease patients

Scientists are reporting promising results in the early stages of a clinical trial designed to gauge the feasibility of a new type of treatment for people with acute kidney disease.

28 Sep 2021

Wildfire smoke is here to stay. Here’s how to clean the air inside your home.

The fierce wildfires that broke out across much of the western United States this summer, spreading smoke across hundreds of miles, continue to pose a serious health hazard to millions.

28 Sep 2021

Caspase-11 identified as regulator of inflammatory pathology in SARS-CoV-2 infections

New findings identify CASP4/11 as detrimental to inflammation and coagulopathy associated with SARS-CoV-2 infection.

28 Sep 2021

Researchers discover protein previously unknown to be involved in SARS-CoV-2 infection

Researchers in the UK and Germany have provided evidence for a novel mechanism by which severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – binds to human host cells.

27 Sep 2021

New WHO Global Air Quality Guidelines recommend new air quality levels to protect human health

New WHO Global Air Quality Guidelines (AQGs) provide clear evidence of the damage air pollution inflicts on human health, at even lower concentrations than previously understood.

27 Sep 2021

Industrial chemical perfluorobutanoic acid less likely to accumulate in human lungs and kidneys

A 2013 study by Pérez et al. reported a very high accumulation of the industrial chemical perfluorobutanoic acid (PFBA) in human lungs and kidneys. The German Federal Institute for Risk Assessment (BfR) checked these results using a more precise quantification method. The result: Only one sample contained a quantifiable PFBA value of 0.17 nanograms (ng) per gram (g) of lung tissue.

25 Sep 2021

Lungs News and Research

COVID-19 survivors under 40 more likely to recover from smell and taste loss, study finds

A possible protective genetic polymorphism in COVID-19

UD chemical engineer aims to improve the delivery of therapeutic medicines to the body

Novel mouse model uncovers resistance mechanism in human breast cancers

J&J vaccine prevents SARS-CoV-2-induced thrombosis and inflammation in hamsters

New AI algorithm may quickly, effectively diagnose deep vein thrombosis

CHLA investigators receive NIH funding to lead study on healthy brain development

Persistent leukocyte changes three months after mild SARS-CoV-2 infection

Hospitalizations related to COVID-19 can be reduced by using prescribed blood thinners

Two-mAb cocktail prevents SARS-CoV-2 infection, study suggests

Dual therapy improves cardiac outcomes in pediatric patients suffering from MIS-C

Pediatric transplant recipients mount a more robust immune response after two COVID-19 vaccine doses

Scientists describe SARS-CoV-2 uptake in tissue-resident human macrophages enhanced by virus-specific antibodies

4DMedical’s unique XV Technology reveals long-term effects of COVID-19

Study reports on ex vivo drug delivery system for delivering MSCs to kidney disease patients

Wildfire smoke is here to stay. Here’s how to clean the air inside your home.

Caspase-11 identified as regulator of inflammatory pathology in SARS-CoV-2 infections

Researchers discover protein previously unknown to be involved in SARS-CoV-2 infection

New WHO Global Air Quality Guidelines recommend new air quality levels to protect human health

Industrial chemical perfluorobutanoic acid less likely to accumulate in human lungs and kidneys

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News